Medical device makers face a perfect storm of innovation pressure and a severe talent shortage, causing development cycles to stretch 18‑24 months. Rapid prototyping technologies can compress these cycles by up to 40%, enabling faster design iteration and ISO 13485‑compliant validation. By digitizing the prototyping workflow and leveraging low‑volume manufacturing, companies reduce reliance on scarce senior engineers and lower overhead costs. The combined approach also strengthens ESG credentials, making firms more attractive to the next generation of engineering talent.

En Carta Diagnostics announced that its EC Pocket Lyme test has received FDA Breakthrough Device Designation, accelerating its path to U.S. market entry. The point‑of‑need molecular assay detects Borrelia DNA directly from skin interstitial fluid using a microneedle sampler, delivering...

Recent data shows 53% of nurses consider leaving monthly, indicating systemic burnout. The national turnover rate of 16.4% costs about $61,110 per replacement, harming patient care and morale. HR leaders must address root causes—understaffing, erratic schedules, limited autonomy—through workforce planning,...
AngioDynamics announced that its NanoKnife system now holds European CE‑mark indications for soft‑tissue ablation of liver, kidney, prostate and pancreas tumours, including intermediate‑risk prostate cancer. The device uses irreversible electroporation (IRE), a non‑thermal technology that destroys cancer cells while sparing...
Serina Therapeutics has enrolled the first patient in its Phase Ib registrational trial of SER‑252 for advanced Parkinson’s disease. The study, conducted with Parkinson’s Australia and Neuroscience Trials Australia, will assess safety, pharmacokinetics, tolerability and early efficacy, with dosing slated to...
Syngene International has entered a strategic collaboration with VivaMed BioPharma to advance AI‑derived drug repurposing programmes. The partnership combines Syngene’s pre‑clinical development capabilities with VivaMed’s AI‑generated therapeutic hypotheses, creating a pathway from computational hits to translational validation. Together they will...

Nivalon, founded by Todd Hodrinsky and Marcel Janse, is preparing to launch its AI‑designed, patient‑specific spinal implant system, EvoFlex, in first‑in‑human trials slated for 2026. The implants are generated through machine‑learning algorithms that model each patient’s vertebral geometry, aiming to...

Professor Matthew Wood, Oxford’s leading neuroscientist, heads the Oxford‑Harrington Rare Disease Centre, a partnership designed to fast‑track therapies for rare neuromuscular and genetic disorders. He outlines a vision to make antisense oligonucleotides (ASOs) and gene‑editing tools more modular, scalable, and...

Leica Biosystems, a Danaher subsidiary, unveiled the Leica CM1950 cryostat equipped with DualEcoTec cooling. The device cools specimens up to three times faster and chambers up to twice as fast, slashing setup and case times. It employs a near‑zero global...

Boehringer Ingelheim received an Emergency Use Authorization (EUA) from the U.S. FDA for its NexGard chewable tablets to treat New World screwworm (NWS) infestations in dogs and puppies, and for NexGard COMBO topical solution to treat NWS in cats and...
University of Bristol engineer Dr. Jiayang Li has created a smart shoe insole equipped with 253 micro‑sensors that map pressure and gait in real time. The device consumes only 100 microwatts, enabling up to three months of operation on a...

China’s medical tourism is gaining traction as foreign patients praise rapid, affordable care in megacities like Shanghai and Beijing. While the absolute number of inbound patients remains modest, industry insiders see a growing pipeline driven by visa‑free entry, expanding international...

Grail announced that its Galleri multi‑cancer blood test failed to achieve the primary endpoint in a large United Kingdom clinical trial. The study, which evaluated the test’s ability to detect early‑stage cancers across dozens of tumor types, showed promising signals...
The U.S. Department of Health and Human Services Office for Civil Rights settled with Top of the World Ranch Treatment Center after a phishing attack exposed ePHI for 1,980 patients. OCR fined the provider $103,000 and imposed a two‑year corrective...
Researchers at the University of Pennsylvania and Harvard have created an ultrathin, flexible electronic mesh that can be implanted into developing pancreatic tissue. The mesh delivers a 24‑hour rhythmic electrical pulse, coaxing stem‑cell‑derived islet cells toward functional maturity and synchronized...

Researchers have demonstrated that combining 18F‑FDG PET with high‑resolution MRI can reliably separate limbic‑predominant age‑related TDP‑43 encephalopathy (LATE) from Alzheimer’s disease in living patients. By creating stereotactic surface projection PET templates from autopsy‑confirmed cases and integrating MRI volumetry, the team...
Stanford researchers have created an intranasal vaccine that elicits a combined innate‑adaptive response, providing broad lung protection in mice. The formulation, containing TLR agonists and a harmless antigen, shielded animals for at least three months against SARS‑CoV‑2, other coronaviruses, two...

Healthcare spending surged as higher service volume boosted hospital revenues but also drove operating costs higher, pushing the median health‑system margin down to 1.3% in December from 1.5% in November. Labor expenses rose 4.2% year‑over‑year while supply costs jumped 12.3%,...

Cityblock Health announced the rollout of its long‑term services and supports (LTSS) program across more than ten states, extending the model that began in Massachusetts and is already active in New York, North Carolina and Indiana. The offering blends regular...

Utah’s Department of Health has green‑lit a 12‑month pilot that lets an approved artificial‑intelligence system automatically process prescription refills for chronic medications. The AI checks dosage, patient history, and insurance eligibility before sending the order to participating pharmacies, aiming to...

Researchers have engineered miniature, three‑dimensional spinal‑cord organoids that can be deliberately injured and subsequently repaired with a biocompatible gel. The gel promotes cell survival and rapid axonal regrowth, effectively modeling the healing cascade observed in vivo. This human‑derived platform provides...

The United Kingdom and Brazil have issued safety warnings linking GLP‑1 weight‑loss drugs to acute pancreatitis after recording 19 and 6 deaths respectively. Reports include roughly 1,300 UK and 145 Brazilian pancreatitis cases among millions of users, though the overall...
Amgen reported double‑digit revenue and earnings growth for 2025, driven by strong performance across its oncology, rare‑disease, biosimilar and general‑medicine portfolios. Fourteen products surpassed $1 billion in sales, with Repatha, Evenity and Tespire each posting over 30% year‑over‑year growth. The company...
The Russian invasion has turned Ukraine’s energy grid into a weapon, leaving maternity hospitals without reliable power, heat, and medical equipment. Repeated strikes have caused 23 major attacks on health facilities this year, pushing premature‑birth rates to twice the national...
ViVE 2025 convened leading health‑tech innovators to examine how security, artificial intelligence and other emerging technologies are reshaping digital health. Speakers highlighted AI‑driven diagnostics, robust cybersecurity frameworks, and interoperable platforms as essential for scaling patient‑centric care. The event also showcased...

A collaborative team led by UNSW and Nutromics has demonstrated a wearable patch that continuously measures vancomycin levels using DNA‑based aptamer sensors. Published in Nature Biotechnology, the pilot trial showed the patch can track drug concentration in interstitial fluid, offering...
The American Hospital Association (AHA) has launched the “We Care, We Vote” campaign to mobilize its member hospitals ahead of the 2026 midterm elections. The initiative offers a dedicated website featuring voter‑registration tools, turnout guides, and a questionnaire that helps...

The National Security Agency has issued a two‑phase Zero Trust Implementation Guidelines to help organizations adopt zero‑trust architecture in line with Department of Defense standards. The guidance details specific activities and requirements, acknowledging that implementation can be resource‑intensive and costly....

Grail’s multi‑cancer blood test Galleri failed to meet its primary endpoint in a large NHS‑partnered study, casting doubt on its early‑detection claims. The test, priced at $1,000, generated $136.8 million from 185,000 units sold in 2025 but remains unapproved by the...

The Administration for Strategic Preparedness and Response (ASPR) announced its first Defense Production Act Title III investment to boost U.S. manufacturing of essential drugs. The funding targets the chronic shortage of oseltamivir, the antiviral known as Tamiflu, by supporting domestic production...

A JAMA study released Feb 18 reveals that 10 % of Medicare Advantage (MA) beneficiaries—about 2.9 million people—must secure alternative coverage for 2026 as plans exit the market, up from 6.9 % in 2025. The displaced enrollees are disproportionately in preferred‑provider‑organization, non‑special‑needs, small‑carrier, and...

FDA Commissioner Tracy Beth Høeg, in her inaugural staff address, announced a renewed focus on evaluating the safety of antidepressants prescribed during pregnancy and monoclonal antibody RSV prophylaxis for infants. She highlighted gaps in existing safety monitoring and pledged more...

HopeHealth, a nonprofit health system serving Rhode Island and southeastern Massachusetts, celebrated its 50th anniversary as the nation’s second hospice and highlighted a period of significant growth in hospice and palliative care. CEO Diana Franchitto noted that aging demographics and...
Novo Nordisk’s shares have slumped 66% from their 2024 peak, reflecting weak 2026 guidance and fierce competition from Eli Lilly in the GLP‑1 arena. The Danish firm recently introduced the first oral GLP‑1 pill, positioning it ahead of Lilly’s upcoming tablet and...
Researchers at Gladstone Institutes discovered that red blood cells (RBCs) act as a primary glucose sink during hypoxia, explaining why people living at high altitude have lower blood sugar. PET/CT scans showed 70% of the extra glucose clearance in hypoxic...

Chronilogix announced an integration that embeds its AI‑powered coaching technology into the Balance for Life wellness app. The combined solution delivers on‑demand behavioral health support for depression, anxiety and stress, while also addressing chronic condition management. By offering 24/7 personalized...

Dock Health announced that its productivity platform is now deployed at Mayo Clinic to automate referral and specialty workflows across cardiovascular, e‑consult and contract programs. The solution creates structured, real‑time workflows that trigger when orders enter the EHR, automatically assigning...
Lonza has expanded its advanced synthesis portfolio to provide end‑to‑end support for antibody‑drug conjugates (ADCs) and other bioconjugates. The company fully integrated the Synaffix‑derived ADC platform—including GlycoConnect® conjugation, HydraSpace® spacers and toxSYN® linker payloads—into its services. A new dual‑payload ADC...

HHS is intensifying its focus on third‑party vendor security after the 2024 Change Healthcare ransomware attack, which exploited a remote‑access portal lacking multifactor authentication and exposed the data of about 190 million individuals. The breach threatened the liquidity of the entire...
The CMS Transforming Episode Accountability Model (TEAM) now holds hospitals financially accountable for costly surgical episodes, prompting a shift toward true specialist collaboration. Hospitals must craft Collaboration Agreements that align incentives, share data, and avoid punitive scoring to keep surgeons...
GE HealthCare announced FDA clearance for three next‑generation MRI products: the 1.5‑T Signa Sprint with Freelium, the 3‑T Signa Bolt, and the AI‑driven workflow platform Signa One. The Sprint uses a helium‑free magnet that consumes less than 1 % of traditional coolant, while the...

MIT researchers have created a miniature ultrasound system roughly the size of a smartphone and costing about $300, capable of capturing real‑time three‑dimensional breast images. The device uses a square‑array probe with CODA geometry, reducing transducer elements from 1,024 to...

Amazfit, Zepp Health’s flagship wearable brand, launched the T‑Rex Ultra 2, a rugged GPS smartwatch aimed at extreme‑environment users. The device combines comprehensive biotracking—heart rate, SpO₂, sleep, breathing, and stress metrics—with 30‑day battery life, 100‑metre water resistance, and a Low Temperature...

Health systems are turning to cloud‑based generative AI to slash documentation overload. City of Hope deployed HopeLLM, an agentic large‑language‑model platform that creates concise medical‑history summaries in minutes, freeing clinicians from nightly “pajama time.” Providence built Provaria on Azure, using...
Britain’s Labour government is under growing pressure over its contracts with U.S. data‑analytics firm Palantir, which include a £330 million NHS platform and a £240 million defence deal awarded without competition. Critics cite the company’s founder Peter Thiel, its work with ICE, and...

Hims & Hers Health announced a definitive agreement to acquire Australian digital‑health firm Eucalyptus for up to $1.15 billion, with $240 million paid in cash and the balance structured as deferred and earn‑out payments. Eucalyptus, founded in 2019, serves more than 775,000...

Verdiva Bio, an obesity‑focused biotech, is gearing up for a data‑heavy 2026, with Phase 2 results for its lead long‑acting peptide slated for the third quarter. The company is also courting strategic partnerships, eyeing potential deals with major pharma players after...

CareYaya, a student‑matching platform, connects college students with seniors and disabled adults to provide non‑medical in‑home assistance. By paying students directly at about $20 an hour, the service reduces care costs roughly 50 % compared with traditional agencies. The app’s algorithm...
BioSpace’s Denatured podcast featured Verdiva Bio’s R&D head Jane Hughes and MitoRx CEO Jon Rees discussing next‑generation obesity therapies that move beyond the limitations of GLP‑1 agonists. They highlighted how GLP‑1 treatments can cause muscle loss and suffer from poor...

MedStar Health is scaling its Signature concierge primary‑care program by partnering with Withings Health Solutions to supply patients with cellular blood‑pressure cuffs and scales. The collaboration leverages MedStar’s existing telehealth and remote‑patient‑monitoring infrastructure to collect real‑world physiologic data outside the...